Search

everythinglearnresearchcommunity

for

Search:↓

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Gut bacteria affect female reproductive health and may help diagnose and treat related diseases.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Healthcare providers should start with simple fertility tests and treatments before referring patients to specialists.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Women with PCOS often experience mental health issues like depression and anxiety.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Family-based treatment is the best outpatient care for stable teens with anorexia, and more research is needed on medication and treatment effectiveness for young people with eating disorders.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Metabolic syndrome reduces effectiveness of hair loss treatment.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Lower 2D:4D finger ratios in HS patients suggest prenatal hormone influence on the disease.

Placental extracts have antioxidant, anti-inflammatory, and immune-boosting effects, but their exact workings are unclear.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.